PureForm Global is the leading manufacturer of cannabinoids for consumer brands and human therapeutics, shaping the future through continuous innovation and commitment to science.
In 2013, we began the effort to replicate the most promising molecules in cannabis without using the plant itself, which is prohibited for all uses in most countries. That year, our team discovered a way to combine components of citrus and those of a unique evergreen shrub to make a bioidentical replica of cannabidiol, or CBD. We spent the next two years developing methods to reliably and consistently replicate the molecule. In 2016, our research led to the development of the first pure, unadulterated, bioidentical CBD. We then went on to perfect our proprietary manufacturing method and in 2017 began industrial-scale production of an over 99.5% pure product. Today, PureForm Global has developed the global capacity to produce its CBD in commercial quantities, at near-perfect purity, with no regulatory barriers.